Literature DB >> 26047763

Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base.

Laura Grimmer1, Erik Liederbach2, Jose Velasco2, Catherine Pesce2, Chi-Hsiung Wang3, Katharine Yao4.   

Abstract

BACKGROUND: The rate of contralateral prophylactic mastectomy (CPM) for unilateral breast cancer has increased over the past decade, particularly for young women. This study investigates the impact of race and socioeconomic status (SES) on use of CPM. STUDY
DESIGN: Using the National Cancer Data Base (NCDB), we selected 1,781,409 stage 0 to II unilateral breast cancer patients between 1998 and 2011. Trends in use of CPM by race and SES were analyzed using chi-square tests and logistic regression models.
RESULTS: For women of all ages, rates of CPM increased, from 1.9% in 1998 to 10.2% in 2011 (p < 0.001), with higher rates in women ≤45 years old, rising from 3.7% in 1998 to 26.2% in 2011 (p < 0.001). Among young women, white women had the greatest increase in CPM from 4.3% in 1998 to 30.2% in 2011 (p < 0.001). In 2011, CPM rates were 30.2% for white, 18.5% for Hispanic, 16.5% for black, and 15.2% for Asian patients (p < 0.001). The gap in CPM use between white and minority patients persisted in every SES classification, geographic region, and facility type. On multivariate analysis, minority women were 50% less likely to undergo CPM than white women were.
CONCLUSIONS: Young, white, breast cancer patients are twice as likely to undergo CPM compared with women in other racial groups, even after accounting for pathologic, patient, and facility factors. Variations in shared decision-making processes between women of different backgrounds may contribute to these trends, supporting the need for future studies investigating decision-making processes and decisional aids.
Copyright © 2015 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26047763     DOI: 10.1016/j.jamcollsurg.2015.03.033

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  20 in total

Review 1.  Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.

Authors:  Giacomo Montagna; Monica Morrow
Journal:  Expert Rev Anticancer Ther       Date:  2020-02-28       Impact factor: 4.512

2.  Emerging trends in surgical and adjuvant radiation therapies among women diagnosed with ductal carcinoma in situ.

Authors:  Oyewale O Shiyanbola; Brian L Sprague; John M Hampton; Kim Dittus; Ted A James; Sally Herschorn; Ronald E Gangnon; Donald L Weaver; Amy Trentham-Dietz
Journal:  Cancer       Date:  2016-05-31       Impact factor: 6.860

3.  Financial Costs and Burden Related to Decisions for Breast Cancer Surgery.

Authors:  Rachel A Greenup; Christel Rushing; Laura Fish; Brittany M Campbell; Lisa Tolnitch; Terry Hyslop; Jeffrey Peppercorn; Stephanie B Wheeler; S Yousuf Zafar; Evan R Myers; E Shelley Hwang
Journal:  J Oncol Pract       Date:  2019-07-29       Impact factor: 3.840

4.  Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.

Authors:  Sonam Sharma; Matthew T McMillan; Abigail Doucette; Roger B Cohen; Abigail Berman; William Levin; Charles B Simone; Jacob Shabason
Journal:  Clin Lung Cancer       Date:  2017-12-14       Impact factor: 4.785

5.  Neoadjuvant Systemic Therapy Use for Younger Patients with Breast Cancer Treated in Different Types of Cancer Centers Across the United States.

Authors:  Jahan J Mohiuddin; Allison M Deal; Lisa A Carey; Jennifer L Lund; Brock R Baker; Timothy M Zagar; Ellen L Jones; Lawrence B Marks; Ronald C Chen
Journal:  J Am Coll Surg       Date:  2016-11       Impact factor: 6.113

6.  Understanding Stakeholder Preference for Contralateral Prophylactic Mastectomy: A Conjoint Analysis.

Authors:  Meghana G Shamsunder; Hina Panchal; Melissa Pilewskie; Clara Lee; Shantanu N Razdan; Evan Matros
Journal:  J Am Coll Surg       Date:  2021-08-23       Impact factor: 6.532

7.  Analysis of a Trend Reversal in US Lumpectomy Rates From 2005 Through 2017 Using 3 Nationwide Data Sets.

Authors:  Jonas A Nelson; Robyn N Rubenstein; Kathryn Haglich; Jacqueline J Chu; Shen Yin; Carrie S Stern; Monica Morrow; Babak J Mehrara; Mary L Gemignani; Evan Matros
Journal:  JAMA Surg       Date:  2022-08-01       Impact factor: 16.681

8.  Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer.

Authors:  Patricia A Parker; Susan K Peterson; Yu Shen; Isabelle Bedrosian; Dalliah M Black; Alastair M Thompson; Jonathan C Nelson; Sarah M DeSnyder; Robert L Cook; Kelly K Hunt; Robert J Volk; Scott B Cantor; Wenli Dong; Abenaa M Brewster
Journal:  J Clin Oncol       Date:  2018-07-25       Impact factor: 44.544

9.  Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.

Authors:  Reshma Jagsi; Sarah T Hawley; Kent A Griffith; Nancy K Janz; Allison W Kurian; Kevin C Ward; Ann S Hamilton; Monica Morrow; Steven J Katz
Journal:  JAMA Surg       Date:  2017-03-01       Impact factor: 16.681

10.  Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer.

Authors:  Steven J Katz; Nancy K Janz; Paul Abrahamse; Lauren P Wallner; Sarah T Hawley; Lawrence C An; Kevin C Ward; Ann S Hamilton; Monica Morrow; Reshma Jagsi
Journal:  JAMA Surg       Date:  2017-07-01       Impact factor: 16.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.